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Abstract
Purpose. Limb-sparing surgery combined with radiation treatment has become the accepted treatment for patients with
high-grade soft-tissue sarcoma. Adjuvant radiation was not routinely used at this institution for patients with clear margins
after surgery.This retrospective review analyses the outcome of this group of patients.
Patients and methods. Patients studied were referred from 1984 to 1995, were over 16 years of age, were diagnosed with
primary high-grade soft-tissue sarcoma of the extremity or super® cial trunk, had clear margins after excision and did not
receive radiation as a part of their initial treatment.A total of 46 patients were identi® ed.
Results. At 5 years, the local control rate was 87%, disease-speci® c survival was 75% and overall survival was 68%. Of the
6 local recurrences, 3 were located in the buttock (from a total of 7 patients with primary tumours of the buttock), 3 had a
primary size of ‡ 10 cm (from a total of 8 primary tumours of that size) and all were deep tumours.
Discussion. Our data, and those from other reports, suggest that in carefully selected patients appropriate surgery alone
results in acceptable local control and survival, and that the morbidity of radiation can be avoided.
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Introduction
Soft tissue sarcomas (STSs) are rare neoplasms,
accounting for approximately 1% of cancer cases
diagnosed annually in the USA.
1 The treatment of
the primary site continues to be re® ned with the
development of newer surgical and radiation
techniques.With surgicaltreatment alone,local recur-
rence (LR) rates are clearly related to the extent of
surgery. After amputation or `radical’ local excision,
LR rates of 2± 13% are reported, compared with
substantially higher LR rates with less radical
surgery.
2,3Thereare now manyreportsdemonstrating
acceptable LR rates after limb-sparingwide local exci-
sion (WLE) combined with pre- or post-operative
radiation treatment.
3± 8 Currently, most cancer treat-
ment centres have adopted limb-sparing surgery and
adjuvant radiation as the treatment of choicefor STS,
and amputation for primary treatment is recom-
mended for very few patients.
9,10
The use of adjuvant radiation, however, is associ-
ated with added morbidity that is not insigni® cant.
Complications including fracture, oedema,
contracture and poor wound healing have been
reported.
11 Because of the morbidity associated with
adjuvant radiation, it has not been used routinely at
our institution in the management of primary STS.
Our practice has been to employ limb-sparingWLE
without radiation therapy for patients with negative
margins following surgery.The purpose of this study
is to review the outcome of 46 patients with high-
gradeSTS of the extremityor super® cial trunktreated
in this fashion.
Methods
All patients aged 16 or more that presented to the
British ColumbiaCancerAgency(BCCA) between 1
January 1984 and 31 December 1995 with high-
grade STS of the extremity and super® cial trunk
were retrospectively reviewed. All patients had a
pathological diagnosis of high-grade STS con® rmed
by central pathology review at the BCCA. The
tumourswere gradedaccordingtothe system of Costa
et al.
12 Patients were excluded from the analysis if
they had metastases or recurrent disease at presenta-
tion, if they received adjuvant radiation treatment for
the primary disease or if the de® nitive surgical
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sparing WLE for extremity sites and WLE for trunk
sites. In the latter part of the 1980s, adjuvant
chemotherapy with doxorubicinand DTIC was used.
Three patients in this study had post-operative
chemotherapy as part of their initial management.
All patients were evaluated prior to surgical resec-
tion by a multidisciplinary team including
Orthopaedics, Radiation Oncology, Medical
Oncology, Radiology and Pathology. For those
patients referred after an incomplete excision
elsewhere,the de® nitive surgicalresectionwas carried
out by an experienced surgical oncologist at the
tertiary care referral hospital affiliated to the BCCA.
The tumour or tumour bed was resected en bloc with
an attempt to resect at least 1 cm margin of normal
tissue around the tumour in all planes. Any previous
drain sites or biopsy scars were included in the resec-
tion. The resection specimen was reviewed by an
experienced pathologist and by the multidisciplinary
team after surgery.Patientswereexcludedif the de® ni-
tive (i.e. ® nal) surgical margin was positive.A margin
was considered positive if tumour cells were seen
within 1 mm of the inked resection margin. Patients
who were notconsideredappropriate for surgeryalone
included the following: those who had a substantial
amount of disease in a re-excision specimen after
prior excisional biopsy; those with `satellite’ nodules;
and patients whose surgery included an anticipated
close margin (e.g. in the region of a neurovascular
bundle or bone).
All patients were followed every 3± 6 months for 5
years and then annually after de® nitive surgicalresec-
tion. Local, regional and distant recurrences were
recorded, as well as disease-speci® c and non-speci® c
patient deaths. Overall survival, disease-speci® c
survival and local and distant recurrence rates were
calculated from the time of de® nitive surgical resec-
tion using the Kaplan± Meier statistical method.
Results
A total of 145 patients aged 16 or older were identi-
® ed throughthe computerizeddatabase of the BCCA
as having high-grade STS of the extremity or
super® cial trunk, referred from January 1984 to
December 1995 and having surgery alone as initial
treatment. Exclusions were as follows: 79 cases with
metastatic or locally recurrent disease at presenta-
tion;10 cases having amputations;and 10 cases having
their primary treatment delivered at another centre.
This left a total of 46 cases, which are the subject of
this review. Patient and tumour details are presented
inTable 1. Only 9 patients had `untouched’ tumours
prior to referral. The remaining 37 patients were
referred after having either an incisional or an exci-
sional biopsy without a pre-operative diagnosis or
imaging.
Median follow-up was 4.4 years (range3± 14 years).
Local control, disease-speci® c survival and overall
survival rates are shown in Figs 1± 3. The 5-year
actuarial local control rate was 87%. The 5-year
actuarial disease-speci® c survival and overall survival
rates were 75% and 68%, respectively. A total of 15
patients died during the observation period, 12 of
disease and 3 from unrelated causes.
The ® nal surgical margin was stated to be nega-
tive, with no measurement given in 21 cases. In 4
cases,the re-excisionspecimencontained no tumour.
The distance of the closest ® nal margin was 1± 4 mm
in 11 cases, 5± 10 mm in 7 cases and >10 mm in 3
cases.
Six patients had an LR and 11 patients had a
distant recurrence. A breakdown of the recurrences
is as follows: local only, 2; local and regional, 1; local
followed by regional, 1; local/regional followed by
distant, 1; distant only, 9; and distant followed by
local, 1.
Of the 6 patients who had an LR, 3 had buttock
primaries (from a total of 7 buttock primaries) and 3
had primary tumours ‡ 10 cm in size (from a total of
8 primaries of that size). Five of the six had biopsies
prior to referral, and 1 patient had an `untouched’
tumour prior to referral.All LRs occurred in patients
with deep tumours; no patient with a super® cial
tumour had an LR. In 2 cases the ® nal margin was
said to be negative, with no measurement given. For
the remaining 4 cases, the closest ® nal margins were
4 mm, 5 mm, 10 mm and 15 mm.
Patients with an LR had repeat excision and/or
radiation therapy. Two of the six remained disease-
free after a minimum follow-up of 3 years.The other
4 patients developed metastatic disease or had
Table 1. Patient and tumour characteristics
Patients
Age at diagnosis Median 63
Gender Male 25
Female 21
Tumours
Size <5 cm 24
5± 9.9 cm 8
‡ 10 cm 8
Unknown* 6
Location Super® cial 17
Deep 29
Trunk 5
Buttock 7
Proximal U/E 7
Proximal L/E 18
Distal U/E 4
Distal L/E 5
Histology MFH 23
Synovial sarcoma 3
Liposarcoma 8
Fibrosarcoma 3
Leiomyosarcoma 6
Other 3
MFH=maligant ® brous histiocytoma, U/E = upper
extremity,L/E = lower extremity.
*No information on size available,tumour resected prior to
referral.
114 L. M.Weir et al.synchronousdistant metastases and all eventuallydied
of their disease. No patient had an amputation for
LR. Of the 9 patients who had distant metastases
alone, 1 had a resection of a pulmonary metastasis
and remains disease-free after 10 years.The other 8
patients died of metastatic disease.
Discussion
The literature is not replete with information about
high-grade sarcoma treated with limb-salvage surgery
without radiotherapy. In Scandinavia there has been
a tradition of treating selected patients with sarcomas
in intramuscularand subcutaneoussites with surgery
alone and this experience has been reviewed by
Rydholm.
13The surgeryfor tumoursin subcutaneous
sites involved an en bloc resection which included the
deep fascia, a 3± 5 cm margin of surrounding tissue
and usually the skin overlying the tumour. Most
patients required skin grafting. After a median
follow-up of 9 years, 4 of 59 high-grade tumours
recurred locally. Patients who had had a previous
biopsy or marginal excision at another centre were
included in this group and did not have a higher
recurrence rate.
Intramuscular tumours were treated with myec-
tomy, with adjacent muscles resected if there was no
fascial boundarybetween them.Only patients without
a previousopenbiopsywere treated this way.Rydholm
reported that 2 of 24 patients had an LR after a
minimum follow-up of 3.5 years. Twenty of these
cases were high-grade sarcomas. The subsequent
clinicalcourseof the patients with LR is not described,
but he concludedthat a local failure rate of 10% does
not justify adjuvant radiation treatment.
Karakousis et al. reported on a group of 152
primaryextremitySTSs,treated in a variety of ways.
14
In this group there were 97 patients with high-grade
tumours treated with wide excision, with or without
chemotherapy, with an LR rate of 12%.
Gibbs et al. reviewed a group of 62 patients with
subcutaneous extremity sarcomas, 35 of whom had
Figure 1. Local control rates.
Figure 2. Disease-speci® c survival rates.
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15Patients with better prognostic
factors (lower grade,smaller size and wider margins)
tended to be selected for surgery alone. There were
no local recurrences in this group after a median
follow-up of 56 months.
Two randomized studies comparing surgery alone
with surgery and radiation have been published.
Pisters et al. reported on the outcome of patients
randomized to surgery alone versus surgery with
brachytherapy, after a median follow-up of 76
months.
16 One hundred and sixty-four patients with
extremity or super® cial trunk sarcomas were rand-
omized. After a gross total resection of the tumour,
patients were randomized intra-operatively to receive
brachytherapy or not.On de® nitive histologicalassess-
ment,29 patients were found to have positive margins
(tumour within 1 mm of a margin). These patients
were distributed evenly in both arms of the study.
Thirty-four patients in each group also received post-
operative chemotherapy. In the group with high-
grade lesions (N=119), actuarial freedom from local
recurrenceat 5 years was 89% for brachytherapy and
66% for no brachytherapy (p=0.003). The bene® t
was con® ned to patients with high-grade tumours.
There was no difference in disease-speci® c survival
or freedom from distant metastases between the two
arms.
Yang et al. published the results of a randomized
study comparing surgery alone with surgery and
external beam radiation in patients with extremity
STS.
17 A total of 141 patients were randomized.
Patients with high-grade tumours(N=91) were rand-
omized to have limb-sparing surgery plus
chemotherapy versus limb-sparing surgery plus
concurrentchemotherapy and radiation.Patients with
a limited positive margin were included. After a
median follow-up of 9.6 years, the actuarial local
failure rate in the chemotherapy alone arm was 22%.
Therewere no LRs in the chemoradiationarm.There
was no differencein the 10-year rate of distant metas-
tases or overall survival between the two arms. Of the
9 patients with an LR, 4 had synchronous distant
metastases and 3 died of metastatic sarcoma. Quality
of life analysis showed that there was a persistent
reduction in joint motion and a transient, but
signi® cant, increase in limb weakness and oedema in
the patients who received radiation therapy.However,
global quality of life and performance in activities of
daily living were not different in the two groups.
Because of the small number of local failures,no risk
factors could be identi® ed for LR (other than lack of
radiation).The authors concluded that, while radia-
tion did reduce the LR rate, no patients with widely
negative margins treated with surgery alone had an
LR. Therefore, for selected patients in whom the
toxicity of radiation is expected to be high and the
LR rate is expected to be low, surgery alone may be
the treatment of choice.
We evaluated patients treated with limb-sparing
surgery for extremity STS and WLE for super® cial
trunk STS.As a matter of policy, if the margins were
clear (no tumour cells within 1 mm of the inked
resection margin), adjuvant radiation was not
routinely given. The distance of the ® nal surgical
margin varied from 1 mm to 20 mm. The LR rate
was 13% at 5 years.The disease-speci® c and overall
survival rates of 75% and 68%, respectively, were
comparable to other reported series where adjuvant
radiation was given routinely. Among the patients
with an LR, tumours located in the buttock and
tumours10 cm or morein size were over-represented.
These patients may not be suitable candidates for
treatment with surgery alone. In addition, the LRs
were seen only in patients with deep tumours.
In the presentseries,no patient had an amputation
for LR. InYang et al.’s study,
17 there were 6 patients
in the no radiation group who had an LR without
distant metastases.Two of these required an amputa-
tion. By way of comparison, Catton et al. reported
that 7 of 25 patients required amputation for LR
after initial treatment with limb-sparing surgery and
radiation.
18 Stinson et al. reported that 3 of 145
Figure 3. Overall survival rates.
116 L. M.Weir et al.patients required an amputation for treatment
complications after limb-sparing surgery and radia-
tion.
11 Even with these small numbers of patients, it
does not appear that avoidance of radiation ultimately
leads to a higher amputation rate because of LR.
These data con® rm other reportsthat surgeryalone
is an acceptable treatment for carefully selected
patients with high-grade STS of the extremity and
super® cial trunk. LR rates of 10± 15% after surgery
alone may not justify routine adjuvant radiation in
these cases.The lowest recurrence rate is seen in the
group with super® cial tumours, even when an inci-
sional or excisional biopsy was performed prior to
referral. Deeply located tumours are more likely to
recur with surgery alone, making this approach less
appropriate. Strict adherence to oncological surgical
principles, careful and thorough assessment of the
pathological specimen and multidisciplinary care are
all essential in selecting patients for this approach.
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